Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases

International Journal of Hematology

Volumn 76, Issue 2, 2002, Pages 186-191

  Fujii, Keiko ^a   Aoyama, Masako ^a   Shinagawa, Katsuji ^a   Matsuo, Keitaro ^a,b   Takenaka, Katsuto ^a   Ikeda, Kazuma ^a   Kojima, Kensuke ^a   Ishimaru, Fumihiko ^a   Kiura, Katsuyuki ^a   Ueoka, Hiroshi ^a   Niiya, Kenji ^a   Tanimoto, Mitsune ^a   Harada, Mine ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation; Elderly; Infectious complications; Neutropenic fever; Risk factor

Indexed keywords

ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CONFIDENCE INTERVAL; FEBRILE NEUTROPENIA; GROUPS BY AGE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION; RISK FACTOR; SOLID TUMOR; ADOLESCENT; ADULT; AGE; AGED; AUTOTRANSPLANTATION; FEMALE; FEVER; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; FEVER; HUMANS; INCIDENCE; INFECTION; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0142044896     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02982583     Document Type: Article

References (29)

1. Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood. 1991;77:400-409.
2. Pettengel R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood. 1993;82:3770-3777.
3. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplant, and allogeneic bone marrow transplant. Bone Marrow Transplant. 1992;9:277-284.
4. Beyer J, Schwella N, Zingsem J, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol. 1995;13:1328-1335.
5. Mossad SB, Longworth DL, Goormastic M, et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant. 1996;18:265-271.
6. Nosanchuck JD, Sepkowitz KA, Pearse RN, et al. Infectious complications of autologous bone marrow and peripheral stem cell transplantation, for refractory leukemia and lymphoma. Bone Marrow Transplant. 1996;18:355-399.
7. D'Antonio D, Iacone A, Pierelli L, et al. Patterns of recovery phase infection after autologous blood progenitor cell transplantation in patients with malignancies: Gruppo Italiano di Studio per la Manipolazione Cellulare in Ematologia. Eur J Clin Microbiol Infect Dis. 1995;14:552-556.
8. Kolbe K, Domkin D, Derigs HG, et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant. 1997;19:143-147.
9. Salazar R, Sola C, Lopez-Lopez JJ, et al. Infectious complications with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;23:27-33.
10. Celebi H, Akan H, Arat M, et al. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant. 2000;26:211-214.
11. Schiodt I, Bergmann OJ, Hansen NE, et al. Early infectious after autologous transplantation for haematological malignancies. Med Oncol. 1998;15:103-108.
12. Offidani M, Corvatta L, Leoni P, et al. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant. 1999;24:1079-1087.
13. Larsson K, Bjorkstrand B, Ljungman P, et al. Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation. Support Care Cancer. 1998;6:378-383.
14. Bessho A, Ueoka H, Harada M, et al. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. Anticancer Res. 1999;19:693-698.
15. Gondo H, Harada M, Miyamoto T, et al. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transplant. 1997;20:821-826.
16. Hughes WT, Armstrong D, Wade JC, et al. From the Infectious Disease Society of America: guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis. 1990;161:381-396.
17. Klastersky J. Empiric treatment of infection during granulocytopenia. Ann Oncol. 1990;1:255-261.
18. Hughes WT, Armstrong D, Young LS, et al. 1997 guidelines for the use of antimicrobial agent in neutropenic patients with unexplained fever: Infectious Disease of America. Clin Infect Dis. 1997;25:551-573.
19. Bearman SI, Appelbaum FR, Thomas ED, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 1988;6:1562-1568.
20. Gorin NC, Labopin M, Pichard P, et al. Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells. Br J Haematol. 2000;110:887-893.
21. de la Rubia J, Saavedra S, Sanz GF, et al. Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:21-25.
22. Salbe CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis. 1991;164:731-740.
23. Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol. 1998;16:1179-1187.
24. Nash RA, Gooley T, Appelbaum FR, et al. The problem of thrombocytopenia after hematopoietic stem cell transplantation. Stem Cells. 1996;14:261-273.
25. Gordon B, Tarantolo S, Haire W, et al. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 1998;22:999-1003.
26. De Pauw BE, Donnelly JP, De Witte T, et al. Options and limitations of long term ciprofloxacin and antibacterial prophylaxis in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1991;5:179-182.
27. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168-1174.
28. Siegert W, Beyer J, Huhn D, et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. J Clin Oncol. 1994;12:1223-1231.
29. Elias AD, Ayash LJ, Antman KH, et al. High-dose ifosfamide/carboplatin/ etoposide with autologous hematopoietic stem cell support: safety and future directions. Semin Oncol. 1994;21:83-85.